Updates in therapeutic drug monitoring in inflammatory bowel disease
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,General Medicine
Reference51 articles.
1. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
2. Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response
3. Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease
4. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
5. Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis;Digestive Diseases and Sciences;2024-06-14
2. Circ_ 0043278 SUPPRESSES MALIGNANT BEHAVIOR OF COLORECTAL CANCER CELLS BY TARGETING miR-6508-3p;POSTEPY BIOL KOMORKI;2024
3. Successful ligelizumab treatment of severe refractory solar urticaria;The Journal of Allergy and Clinical Immunology: In Practice;2023-08
4. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-03-23
5. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review;Nutrients;2022-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3